The purpose of our study was to formulate and evaluate bicalutamide (BL) solid dispersions (SD). The physicochemical properties were evaluated by differential scanning calorimetry (DSC), Fourier-Transform infrared (FT-IR) spectroscopy, Powder X-ray diffractometry (PXRD), dissolution studies, and stability studies. The dissolution studies demonstrated that the dissolution of BL from BL-SD increased with an increase in carrier content (PVP K30). X-ray assays and DSC results both confirmed the amorphous state of BL in BL-SD. Stability studies conducted after 6 months showed that BL exhibited excellent stability in the solid dispersion of PVP K30 (1:5).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/03639040600637606 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical research progress of ridaforolimus (AP23573, MK8668) over the past decade: a systemic review.
Front Pharmacol
March 2024
Zhongshan Hospital (Xiamen), Fudan University, Xiamen, Fujian Province, China.
Rapamycin, an established mTOR inhibitor in clinical practice, is widely recognized for its therapeutic efficacy. Ridaforolimus, a non-prodrug rapalog, offers improved aqueous solubility, stability, and affinity compared to rapamycin. In recent years, there has been a surge in clinical trials involving ridaforolimus.
View Article and Find Full Text PDFHeterochronous multiple primary prostate cancer and lymphoma: A case report.
World J Clin Cases
March 2024
Department of Oncology, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China.
Article Synopsis
- * The patient, a 77-year-old male, was initially treated for prostate cancer with radiation and endocrine therapy, but later developed rectal DLBCL with lung metastases seven years after the prostate cancer diagnosis.
- * The case highlights the importance of recognizing the possibility of coexisting cancers, even though it is uncommon, which can enhance understanding of cancer progression and treatment.
Experience and Lessons Learned in the Treatment of Transforming Small Cell Neuroendocrine Carcinoma of the Prostate: A Case Report and Literature Review.
Case Rep Oncol
February 2024
Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, China.
Article Synopsis
- Small cell neuroendocrine carcinoma of the prostate (SCNECP) is a rare, aggressive cancer type that often develops from conventional prostate adenocarcinoma (CPAC), typically diagnosed at advanced stages with metastasis to organs like the liver and lungs.
- * A case study of a 73-year-old man reveals that despite initial treatment leading to a decrease in prostate-specific antigen (PSA) levels, other tumor markers began to rise, indicating potential transformation to SCNECP.
- * The findings suggest that monitoring tumor markers beyond just PSA is crucial for early detection of SCNECP, as a rise in markers like CEA, CA199, and CA125 may signal an important change in the disease's progression.*
Risk Factors for Bisphosphonate-Related Osteonecrosis of the Jaws in Bone Metastatic Breast and Prostate Cancer under Zoledronate Treatment: A Retrospective Analysis from 10 Years of Evaluation.
Asian Pac J Cancer Prev
August 2023
Department of Dental Clinic, Division of Oral Pathology, Faculty of Pharmacy, Dentistry and Nursing, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Objective: This study aims to analyze the risk factors for BRONJ in patients taking zoledronic acid (ZA) for metastatic breast and prostate cancer.
Methods: For this, a retrospective, quantitative, observational cohort study was conducted using data on adverse effects in the oral cavity in patients during chemotherapy for treatment of solid tumors available in the electronic patient record system of the Haroldo Juaçaba Hospital/Ceará Cancer Institute in the period from 2010, to 2019. Data were tabulated in Excel and exported to SPSS v20.
Novel Paired Normal Prostate and Prostate Cancer Model Cell Systems Derived from African American Patients.
Cancer Res Commun
December 2022
Department of Radiation Medicine, Georgetown University School of Medicine, Washington, District of Columbia.
Unlabelled: Prostate cancer is the most frequently diagnosed solid malignancy in men. African American (AA) men are at greater risk for developing prostate cancer, and experience higher mortality rates, as compared with Caucasian American men. However, mechanistic studies to understand this health disparity have been limited by the lack of relevant and models.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!